When does outsourcing autologous collection center qualification and the cell therapy supply chain make sense?

Amy Hines BSN, RN is the Vice President of Apheresis Strategy at Cryoport Systems, where she supports IntegriCell™ cryopreservation services. With a background in oncology and transplant nursing, Amy brings over 25 years of cellular therapy experience to her role. Before joining Cryoport Systems, Amy worked with NMDP and NMDP-BT where her responsibilities included oversight of apheresis and marrow collection network partner activities. She is mission-driven and known for her leadership, strategic thinking, and collaborative, innovative approach in tackling challenges. In her free time, Amy enjoys gardening, tending to her small farm, and enjoying the Northern Michigan outdoors.

As Senior Director, Operations, Jeni leads the SupplyChain (logistics and case management), Donor (donor screening and workup),Network (onboarding and expertise associated with apheresis), ProcessDocumentation & Improvement and Vendor teams. She and her teams arededicated to the flawless delivery of services for cell and gene therapydevelopers.Prior to her current role, Jeni held leadershippositions in the NMDP parent organization as a leader in the Donor Contactteams, Director of Case Management and Senior Director of OperationalExcellence, where she most recently provided strategic direction and leadershipto a group that maintained relationships with over 140 domestic transplantcenters and led the relationship with 80 international partners. Growing thatteam to support increasing volumes while strategically changing how theysupported the NMDP vision, she delivered a 98% satisfaction rating withcustomers.During the COVID-19 pandemic, Jeni led manyoperational initiatives while maintaining global operations. Additionally, Jeniled the deployment of new functionality for our customers, increasing customersatisfaction with the application from 70% to 97% in 5 years.Jeni earned a bachelor’s degree in Biology from theUniversity of Minnesota Duluth.

Seasoned professional serving the Cell and Gene Therapy Landscape for Clinical & Commercial Ultra Rare Diseases (i.e. MLD - Metachromatic Leukodystrophy) as Director Global Supply Chain & Distribution

as well as heading the Site Qualification Team for qualifying QTC / ATC (qualified / authorized treatment centres) globally for autologous treatments.

25+ years history as Supply Chain and Procurement Leader in Cell & Gene, Medical Devices, Aviation and Real Estate.